リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Timing of therapeutic interventions against infection-triggered encephalopathy syndrome: a scoping review of the pediatric literature」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。
リケラボ

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Timing of therapeutic interventions against infection-triggered encephalopathy syndrome: a scoping review of the pediatric literature

Nagase, Hiroaki Yamaguchi, Hiroshi Tokumoto, Shoichi Ishida, Yusuke Tomioka, Kazumi Nishiyama, Masahiro Nozu, Kandai Maruyama, Azusa 神戸大学

2023.08.22

概要

Our goal was to conduct a scoping review of the literature on the treatment of infection-triggered encephalopathy syndrome/acute encephalopathy in children, focusing on treatment targets and treatment initiation timing. We performed literature searches using PubMed for articles reporting treatments of infection-triggered encephalopathy syndrome/acute encephalopathy. We included articles describing specific treatments for acute encephalopathy with control groups. For the purpose of searching new therapies only experimentally tried in the case series, we also included case series studies without control groups in this review, if the studies contained at least two cases with clear treatment goals. Therapies were classified based on their mechanisms of action into brain protection therapy, immunotherapy, and other therapies. We operationally categorized the timing of treatment initiation as T1 (6–12 h), T2 (12–24 h), T3 (24–48 h), and T4 (>48 h) after the onset of seizures and/or impaired consciousness. Thirty articles were included in this review; no randomized control study was found. Eleven retrospective/historical cohort studies and five case–control studies included control groups with or without specific therapies or outcomes. The targeted conditions and treatment timing varied widely across studies. However, the following three points were suggested to be effective in multiple studies: (1) Careful seizure management and targeted temperature management within 12 h (T1) of onset of febrile seizure/prolonged impaired consciousness without multiple organ failure may reduce the development of acute encephalopathy with biphasic seizures and late reduced diffusion; (2) immunotherapy using corticosteroids, tocilizumab, or plasma exchange within 24 h (T1–T2) of onset of acute necrotizing encephalopathy may reduce sequelae; and (3) anakinra therapy and ketogenic diet demonstrate little evidence of neurologic sequelae reduction, but may reduce seizure frequency and allow for weaning from barbiturates, even when administered weeks (T4) after onset in children with febrile infection-related epilepsy syndrome. Although available studies have no solid evidence in the treatment of infection-triggered encephalopathy syndrome/acute encephalopathy, this scoping review lays the groundwork for future prospective clinical trials.

論文の公開元へ

この論文で使われている画像

関連論文

関連論文をもっと見る

参考文献

Boutros, A., Hoyt, J., Menezes, A., and Bell, W. (1977). Management of Reye's

syndrome. A rational approach to a complex problem. Crit. Care Med. 5, 234–238. doi:

10.1097/00003246-197709000-00005

Legriel, S., Lemiale, V., Schenck, M., Chelly, J., Laurent, V., Daviaud, F., et al. (2016).

Hypothermia for neuroprotection in convulsive status epilepticus. N. Engl. J. Med. 375,

2457–2467. doi: 10.1056/NEJMoa1608193

Clarkson, B. D. S., LaFrance-Corey, R. G., Kahoud, R. J., Farias-Moeller, R.,

Payne, E. T., and Howe, C. L. (2019). Functional deficiency in endogenous interleukin-1

receptor antagonist in patients with febrile infection-related epilepsy syndrome. Ann.

Neurol. 85, 526–537. doi: 10.1002/ana.25439

Li, K., Zhang, T., Liu, G., Jin, P., Wang, Y., Wang, L., et al. (2021). Plasma exchange

therapy for acute necrotizing encephalopathy of childhood. Pediatr. Investig. 5, 99–105.

doi: 10.1002/ped4.12280

Lin, J. J., Lin, K. L., Hsia, S. H., and Wang, H. S.Group, C.S (2012). Therapeutic

hypothermia for febrile infection-related epilepsy syndrome in two patients. Pediatr.

Neurol. 47, 448–450. doi: 10.1016/j.pediatrneurol.2012.08.013

Fukui, K. O., Kubota, M., Terashima, H., Ishiguro, A., and Kashii, H. (2019). Early

administration of vitamins B1 and B6 and l-carnitine prevents a second attack of acute

encephalopathy with biphasic seizures and late reduced diffusion: a case control study.

Brain Dev. 41, 618–624. doi: 10.1016/j.braindev.2019.02.015

Marshall, L. F., Shapiro, H. M., Rauscher, A., and Kaufman, N. M. (1978). Pentobarbital

therapy for intracranial hypertension in metabolic coma. Reye's syndrome. Crit. Care

Med. 6, 1–5. doi: 10.1097/00003246-197801000-00001

Hayakawa, I., Okubo, Y., Nariai, H., Michihata, N., Matsui, H., Fushimi, K., et al.

(2020). Recent treatment patterns and variations for pediatric acute encephalopathy in

Japan. Brain Dev. 42, 48–55. doi: 10.1016/j.braindev.2019.08.007

Matsuo, M., Maeda, T., Ono, N., Sugihara, S., Kobayashi, I., Koga, D., et al. (2013).

Efficacy of dextromethorphan and cyclosporine a for acute encephalopathy. Pediatr.

Neurol. 48, 200–205. doi: 10.1016/j.pediatrneurol.2012.11.003

Hayashi, N., Okumura, A., Kubota, T., Tsuji, T., Kidokoro, H., Fukasawa, T., et al.

(2012). Prognostic factors in acute encephalopathy with reduced subcortical diffusion.

Brain Dev. 34, 632–639. doi: 10.1016/j.braindev.2011.11.007

Mizuguchi, M., Ichiyama, T., Imataka, G., Okumura, A., Goto, T., Sakuma, H., et al.

(2021). Guidelines for the diagnosis and treatment of acute encephalopathy in

childhood. Brain Dev. 43, 2–31. doi: 10.1016/j.braindev.2020.08.001

Hemmen, T. M., Raman, R., Guluma, K. Z., Meyer, B. C., Gomes, J. A., Cruz-Flores, S.,

et al. (2010). Intravenous thrombolysis plus hypothermia for acute treatment of ischemic

stroke (ICTuS-L): final results. Stroke 41, 2265–2270. doi: 10.1161/

STROKEAHA.110.592295

Mizuguchi, M., Yamanouchi, H., Ichiyama, T., and Shiomi, M. (2007). Acute

encephalopathy associated with influenza and other viral infections. Acta Neurol. Scand.

115, 45–56. doi: 10.1111/j.1600-0404.2007.00809.x

Horino, A., Kuki, I., Inoue, T., Nukui, M., Okazaki, S., Kawawaki, H., et al. (2021).

Intrathecal dexamethasone therapy for febrile infection-related epilepsy syndrome. Ann.

Clin. Transl. Neurol. 8, 645–655. doi: 10.1002/acn3.51308

Morishima, T. (2006). Guideline for the management of influenza associated

encephalopathy. Nihon Rinsho 64, 1897–1905.

Murata, S., Kashiwagi, M., Tanabe, T., Oba, C., Shigehara, S., Yamazaki, S., et al.

(2016). Targeted temperature management for acute encephalopathy in a Japanese

secondary emergency medical care hospital. Brain Dev. 38, 317–323. doi: 10.1016/j.

braindev.2015.09.003

Hoshide, M., Yasudo, H., Inoue, H., Matsushige, T., Sakakibara, A., Nawata, Y., et al.

(2020). Efficacy of hypothermia therapy in patients with acute encephalopathy with

biphasic seizures and late reduced diffusion. Brain Dev. 42, 515–522. doi: 10.1016/j.

braindev.2020.03.007

Murofushi, Y., Sakuma, H., Tada, H., Mizuguchi, M., and Takanashi, J. I. (2022).

Changes in the treatment of pediatric acute encephalopathy in Japan between 2015 and

2021: a national questionnaire-based survey. Brain Dev. 45, 153–160. doi: 10.1016/j.

braindev.2022.10.008

Hosie, P. H., Lim, C., Scott, T. R. D., Cardamone, M., Farrar, M. A., Frith, C., et al.

(2023). Treatment of severe acute necrotizing encephalopathy of childhood with

interleukin-6 receptor blockade in the first 24 h as add-on immunotherapy shows

favorable long-term outcome at 2 years. Brain Dev. 45, 401–407. doi: 10.1016/j.

braindev.2023.03.002

Nabbout, R., Mazzuca, M., Hubert, P., Peudennier, S., Allaire, C., Flurin, V., et al.

(2010). Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever

induced refractory epileptic encephalopathy in school age children (FIRES). Epilepsia

51, 2033–2037. doi: 10.1111/j.1528-1167.2010.02703.x

Hutchison, J. S., Ward, R. E., Lacroix, J., Hebert, P. C., Barnes, M. A., Bohn, D. J., et al.

(2008). Hypothermia therapy after traumatic brain injury in children. N. Engl. J. Med.

358, 2447–2456. doi: 10.1056/NEJMoa0706930

Nagase, H., Nakagawa, T., Aoki, K., Fujita, K., Saji, Y., Maruyama, A., et al. (2013).

Therapeutic indicators of acute encephalopathy in patients with complex febrile seizures.

Pediatr. Int. 55, 310–314. doi: 10.1111/ped.12046

Hypothermia after Cardiac Arrest Study Group (2002). Mild therapeutic hypothermia

to improve the neurologic outcome after cardiac arrest. N. Engl. J. Med. 346, 549–556.

doi: 10.1056/NEJMoa012689

Nielsen, N., Wetterslev, J., Cronberg, T., Erlinge, D., Gasche, Y., Hassager, C., et al.

(2013). Targeted temperature management at 33 degrees C versus 36 degrees C after

cardiac arrest. N. Engl. J. Med. 369, 2197–2206. doi: 10.1056/NEJMoa1310519

Ishida, Y., Nishiyama, M., Yamaguchi, H., Tomioka, K., Takeda, H., Tokumoto, S., et al.

(2021). Early steroid pulse therapy for children with suspected acute encephalopathy:

an observational study. Medicine 100:e26660. doi: 10.1097/MD.0000000000026660

Nishiyama, M., Tanaka, T., Fujita, K., Maruyama, A., and Nagase, H. (2015). Targeted

temperature management of acute encephalopathy without AST elevation. Brain Dev.

37, 328–333. doi: 10.1016/j.braindev.2014.06.005

Kasai, M., Shibata, A., Hoshino, A., Maegaki, Y., Yamanouchi, H., Takanashi, J. I., et al.

(2020). Epidemiological changes of acute encephalopathy in Japan based on national

surveillance for 2014–2017. Brain Dev. 42, 508–514. doi: 10.1016/j.braindev.2020.04.006

Okajima, K., Hayakawa, I., Tsuboi, N., Shimura, K., Ishiguro, A., and Abe, Y. (2022).

Early therapeutic plasma exchange may lead to complete neurological recovery in

moderate to severe influenza-associated acute necrotizing encephalopathy. Brain Dev.

44, 492–497. doi: 10.1016/j.braindev.2022.03.004

Kawamura, Y., Nakai, H., Sugata, K., Asano, Y., and Yoshikawa, T. (2013). Serum

biomarker kinetics with three different courses of HHV-6B encephalitis. Brain Dev. 35,

590–595. doi: 10.1016/j.braindev.2012.08.005

Kawano, G., Iwata, O., Iwata, S., Kawano, K., Obu, K., Kuki, I., et al. (2011).

Determinants of outcomes following acute child encephalopathy and encephalitis:

pivotal effect of early and delayed cooling. Arch. Dis. Child. 96, 936–941. doi: 10.1136/

adc.2009.180554

Okumura, A., Mizuguchi, M., Kidokoro, H., Tanaka, M., Abe, S., Hosoya, M., et al.

(2009). Outcome of acute necrotizing encephalopathy in relation to treatment with

corticosteroids and gammaglobulin. Brain Dev. 31, 221–227. doi: 10.1016/j.

braindev.2008.03.005

Koh, J. C., Murugasu, A., Krishnappa, J., and Thomas, T. (2019). Favorable outcomes

with early interleukin 6 receptor blockade in severe acute necrotizing encephalopathy

of childhood. Pediatr. Neurol. 98, 80–84. doi: 10.1016/j.pediatrneurol.2019.04.009

Omata, T., Fujii, K., Takanashi, J., Murayama, K., Takayanagi, M., Muta, K., et al.

(2016). Drugs indicated for mitochondrial dysfunction as treatments for acute

encephalopathy with onset of febrile convulsive status epileptics. J. Neurol. Sci. 360,

57–60. doi: 10.1016/j.jns.2015.11.043

Kuki, I., Inoue, T., Nukui, M., Okazaki, S., Kawawaki, H., Ishikawa, J., et al. (2022).

Effect of higher body temperature and acute brain edema on mortality in hemorrhagic

shock and encephalopathy syndrome. J. Neurol. Sci. 439:120321. doi: 10.1016/j.

jns.2022.120321

Polderman, K. H. (2008). Induced hypothermia and fever control for prevention and

treatment of neurological injuries. Lancet 371, 1955–1969. doi: 10.1016/

s0140-6736(08)60837-5

Lai, Y. C., Muscal, E., Wells, E., Shukla, N., Eschbach, K., Hyeong Lee, K., et al. (2020).

Anakinra usage in febrile infection related epilepsy syndrome: an international cohort.

Ann. Clin. Transl. Neurol. 7, 2467–2474. doi: 10.1002/acn3.51229

Sa, M., Singh, R., Pujar, S., D'Arco, F., Desai, N., Eltze, C., et al. (2019). Centromedian

thalamic nuclei deep brain stimulation and Anakinra treatment for FIRES - two different

outcomes. Eur. J. Paediatr. Neurol. 23, 749–754. doi: 10.1016/j.ejpn.2019.08.001

Lee, C. G., Kim, J. H., Lee, M., and Lee, J. (2014). Clinical outcome of acute necrotizing

encephalopathy in related to involving the brain stem of single institution in Korea.

Korean J. Pediatr. 57, 264–270. doi: 10.3345/kjp.2014.57.6.264

Sakata, K., Kawano, G., Suda, M., Yokochi, T., Yae, Y., Imagi, T., et al. (2020).

Determinants of outcomes for acute encephalopathy with reduced subcortical diffusion.

Sci. Rep. 10:9134. doi: 10.1038/s41598-020-66167-7

Frontiers in Neuroscience

39

frontiersin.org

Nagase et al.

10.3389/fnins.2023.1150868

Sasaki, K., Nagase, H., Maruyama, A., Fujita, K., Nishiyama, M., Tanaka, T., et al.

(2017). Clinical prediction rule for neurological sequelae due to acute encephalopathy:

a medical community-based validation study in Harima Japan. BMJ Open 7:e016675.

doi: 10.1136/bmjopen-2017-016675

Tomioka, K., Nishiyama, M., Tokumoto, S., Yamaguchi, H., Aoki, K., Seino, Y., et al.

(2023). Time course of serum cytokine level changes within 72 h after onset in children

with acute encephalopathy and febrile seizures. BMC Neurol. 23:7. doi: 10.1186/

s12883-022-03048-8

Seo, H. E., Hwang, S. K., Choe, B. H., Cho, M. H., Park, S. P., and Kwon, S. (2010).

Clinical spectrum and prognostic factors of acute necrotizing encephalopathy in

children. J. Korean Med. Sci. 25, 449–453. doi: 10.3346/jkms.2010.25.3.449

Tricco, A. C., Lillie, E., Zarin, W., O'Brien, K. K., Colquhoun, H., Levac, D., et al.

(2018). PRISMA extension for scoping reviews (PRISMA-ScR): checklist and

explanation. Ann. Intern. Med. 169, 467–473. doi: 10.7326/M18-0850

Shankaran, S., Laptook, A. R., Ehrenkranz, R. A., Tyson, J. E., McDonald, S. A.,

Donovan, E. F., et al. (2005). Whole-body hypothermia for neonates with hypoxicischemic encephalopathy. N. Engl. J. Med. 353, 1574–1584. doi: 10.1056/NEJMcps050929

Watanabe, Y., Motoi, H., Oyama, Y., Ichikawa, K., Takeshita, S., Mori, M., et al. (2014).

Cyclosporine for acute encephalopathy with biphasic seizures and late reduced diffusion.

Pediatr. Int. 56, 577–582. doi: 10.1111/ped.12288

Shrestha, A., Wood, E. L., Berrios-Siervo, G., Stredny, C. M., Boyer, K., Vega, C., et al.

(2023). Long-term neuropsychological outcomes in children with febrile infectionrelated epilepsy syndrome (FIRES) treated with anakinra. Front. Neurol. 14:1100551.

doi: 10.3389/fneur.2023.1100551

Wickstrom, R., Taraschenko, O., Dilena, R., Payne, E. T., Specchio, N., Nabbout, R., et al.

(2022). International consensus recommendations for management of new onset refractory

status epilepticus (NORSE) including febrile infection-related epilepsy syndrome (FIRES):

summary and clinical tools. Epilepsia 63, 2827–2839. doi: 10.1111/epi.17391

Singh, R. K., Joshi, S. M., Potter, D. M., Leber, S. M., Carlson, M. D., and Shellhaas, R. A.

(2014). Cognitive outcomes in febrile infection-related epilepsy syndrome treated with the

ketogenic diet. Pediatrics 134, e1431–e1435. doi: 10.1542/peds.2013-3106

Yamaguchi, H., Nishiyama, M., Tokumoto, S., Ishida, Y., Tomioka, K., Aoki, K., et al.

(2020). Detailed characteristics of acute encephalopathy with biphasic seizures and late

reduced diffusion: 18-year data of a single-center consecutive cohort. J. Neurol. Sci.

411:116684. doi: 10.1016/j.jns.2020.116684

Takanashi, J., Tada, H., Terada, H., and Barkovich, A. J. (2009). Excitotoxicity in acute

encephalopathy with biphasic seizures and late reduced diffusion. AJNR Am. J.

Neuroradiol. 30, 132–135. doi: 10.3174/ajnr.A1247

Yamaguchi, H., Nishiyama, M., Tokumoto, S., Ishida, Y., Tomioka, K., Aoki, K., et al.

(2021). Elevated cytokine, chemokine, and growth and differentiation factor-15 levels

in hemorrhagic shock and encephalopathy syndrome: a retrospective observational

study. Cytokine 137:155324. doi: 10.1016/j.cyto.2020.155324

Takanashi, J., Taneichi, H., Misaki, T., Yahata, Y., Okumura, A., Ishida, Y., et al. (2014).

Clinical and radiologic features of encephalopathy during 2011 E coli O111 outbreak in

Japan. Neurology 82, 564–572. doi: 10.1212/WNL.0000000000000120

Zhu, H. M., Zhang, S. M., Yao, C., Luo, M. Q., Ma, H. J., Lei, T., et al. (2021). The

clinical and imaging characteristics associated with neurological sequelae of Pediatric

patients with acute necrotizing encephalopathy. Front. Pediatr. 9:655074. doi: 10.3389/

fped.2021.655074

Tokumoto, S., Nishiyama, M., Yamaguchi, H., Tomioka, K., Ishida, Y., Toyoshima, D.,

et al. (2022). Prognostic effects of treatment protocols for febrile convulsive status

epilepticus in children. BMC Neurol. 22:77. doi: 10.1186/s12883-022-02608-2

Frontiers in Neuroscience

40

frontiersin.org

...

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文
を
一発検索！

この論文の関連論文を見る